CD3+, encompassing both CD8+ and CD4+ T-helper cells, and CD8+ cells also have different densities in different areas of the tumor, and the evaluation has to be performed twice for each of these markers on consecutive slides. This evidence concerns the gene CD4 and neoplasm.